These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8880930)

  • 1. Structural stability of disulfide mutants of basic pancreatic trypsin inhibitor: a molecular dynamics study.
    Schiffer CA; van Gunsteren WF
    Proteins; 1996 Sep; 26(1):66-71. PubMed ID: 8880930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretion efficiency in Saccharomyces cerevisiae of bovine pancreatic trypsin inhibitor mutants lacking disulfide bonds is correlated with thermodynamic stability.
    Kowalski JM; Parekh RN; Wittrup KD
    Biochemistry; 1998 Feb; 37(5):1264-73. PubMed ID: 9477952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between disulfide reduction and conformational unfolding in bovine pancreatic trypsin inhibitor.
    Ma LC; Anderson S
    Biochemistry; 1997 Mar; 36(12):3728-36. PubMed ID: 9132026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrophobic interactions accelerate early stages of the folding of BPTI.
    Dadlez M
    Biochemistry; 1997 Mar; 36(10):2788-97. PubMed ID: 9062106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of hydrogen bonding residues in the BPTI folding pathway.
    Bulaj G; Goldenberg DP
    J Mol Biol; 2001 Oct; 313(3):639-56. PubMed ID: 11676545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution structure of bovine pancreatic trypsin inhibitor with altered binding loop sequence.
    Czapinska H; Otlewski J; Krzywda S; Sheldrick GM; Jaskólski M
    J Mol Biol; 2000 Feb; 295(5):1237-49. PubMed ID: 10653700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated exchange of a buried water molecule in selectively disulfide-reduced bovine pancreatic trypsin inhibitor.
    Denisov VP; Peters J; Hörlein HD; Halle B
    Biochemistry; 2004 Sep; 43(38):12020-7. PubMed ID: 15379542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Designing out" disulfide bonds: thermodynamic properties of 30-51 cystine substitution mutants of bovine pancreatic trypsin inhibitor.
    Liu Y; Breslauer K; Anderson S
    Biochemistry; 1997 May; 36(18):5323-35. PubMed ID: 9154914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folding of bovine pancreatic trypsin inhibitor (BPTI) variants in which almost half the residues are alanine.
    Kuroda Y; Kim PS
    J Mol Biol; 2000 May; 298(3):493-501. PubMed ID: 10772865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phi-values for BPTI folding intermediates and implications for transition state analysis.
    Bulaj G; Goldenberg DP
    Nat Struct Biol; 2001 Apr; 8(4):326-30. PubMed ID: 11276252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of backbone dynamics in native BPTI: cooperative influence of the 14-38 disulfide and the Tyr35 side-chain.
    Beeser SA; Oas TG; Goldenberg DP
    J Mol Biol; 1998 Dec; 284(5):1581-96. PubMed ID: 9878372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of single-disulfide variants of bovine pancreatic trypsin inhibitor (BPTI) as probed by their binding to bovine beta-trypsin.
    Krokoszynska I; Dadlez M; Otlewski J
    J Mol Biol; 1998 Jan; 275(3):503-13. PubMed ID: 9466927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of the residual structure in unfolded BPTI in different conditions of temperature and solvent composition measured by disulphide kinetics and double mutant cycle analysis.
    Zdanowski K; Dadlez M
    J Mol Biol; 1999 Mar; 287(2):433-45. PubMed ID: 10080904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformation of native, reduced and [5-55]Ala bovine pancreatic trypsin inhibitor in the gas phase.
    Nesatiy V; Chen YL; Collings BA; Douglas DJ
    Rapid Commun Mass Spectrom; 1998; 12(1):40-4. PubMed ID: 9450353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein unfolding pathways explored through molecular dynamics simulations.
    Daggett V; Levitt M
    J Mol Biol; 1993 Jul; 232(2):600-19. PubMed ID: 7688428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of individual side-chains to the stability of BPTI examined by alanine-scanning mutagenesis.
    Yu MH; Weissman JS; Kim PS
    J Mol Biol; 1995 Jun; 249(2):388-97. PubMed ID: 7540212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and internal dynamics of the bovine pancreatic trypsin inhibitor in aqueous solution from long-time molecular dynamics simulations.
    Brunne RM; Berndt KD; Güntert P; Wüthrich K; van Gunsteren WF
    Proteins; 1995 Sep; 23(1):49-62. PubMed ID: 8539250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The disulfide folding pathway of tick anticoagulant peptide (TAP), a Kunitz-type inhibitor structurally homologous to BPTI.
    Chang JY
    Biochemistry; 1996 Sep; 35(36):11702-9. PubMed ID: 8794751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Entropic folding pathway of human epidermal growth factor explored by disulfide scrambling and amplified collective motion simulations.
    Zhang Z; Boyle PC; Lu BY; Chang JY; Wriggers W
    Biochemistry; 2006 Dec; 45(51):15269-78. PubMed ID: 17176049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Balancing conformational and oxidative kinetic traps during the folding of bovine pancreatic trypsin inhibitor (BPTI) with glutathione and glutathione disulfide.
    Kibria FM; Lees WJ
    J Am Chem Soc; 2008 Jan; 130(3):796-7. PubMed ID: 18166059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.